Pharmaceutical Technology

APRIL 17, 2023

NKGen Biotech, a clinical-stage natural killer (NK) cell therapy firm, has signed a definitive agreement to combine its business operations with Graf Acquisition. The merger is scheduled to be completed by the third quarter of 2023. Topic sponsors are not involved in the creation of editorial content.

Patients 98

Patients Leads Pharmaceutical Marketing 98

Pharmaceutical Technology

OCTOBER 18, 2022

Oculis has signed a definitive business combination agreement with special purpose acquisition company (SPAC) European Biotech Acquisition (EBAC). OCS-02 is a topical anti-TNF alpha monoclonal antibody fragment, while OCS-05 is an activator of serum-glucocorticoid kinase 2.

Specialization 59

Specialization Management Medical Pharmaceutical 59

Pharmaceutical Technology

MAY 5, 2023

The deal includes an option for Siegfried to purchase this remaining 5% five years after the acquisition. Topic sponsors are not involved in the creation of editorial content. Siegfried will leverage DiNAMIQS’ capabilities to commercial scale by constructing a facility that complies with good manufacturing practice standards.

Leads 52

Leads Manufacturing Management Pharmaceutical 52

Pharmaceutical Technology

DECEMBER 27, 2022

Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced. Along the way, mergers and acquisitions continued to happen, new drugs and devices got approved, and innovations in the clinical trial industry were introduced.

Healthcare 122

Healthcare Healthcare Pharma Medical 122

Pharmaceutical Technology

DECEMBER 1, 2022

Liminatus Pharma has entered a definitive business combination agreement with special purpose acquisition company (SPAC) Iris Acquisition to create a business with a pro forma enterprise value of nearly $334m. The boards of directors of both companies have granted approval for the merger. Free Whitepaper.

Pharma 52

Pharma Specialization Marketing Leads 52

PM360

DECEMBER 20, 2023

Furthermore, merger and acquisitions (M&A) in the biotech industry also declined in Q3 2023 after a promising start to the year, according to Evaluate, a Norstella Company. and 10X Capital Venture Acquisition Corp. This method is often quicker than a public offering and has less strict regulations.

Management 109

Management Marketing Healthcare Healthcare 109

Pharmaceutical Representative Training

JANUARY 11, 2021

The program covers all of the most important topics any pharma sales rep needs to know including pharmacology, medical terminology, pharma industry compliance, selling skills and many other important topics. That product may be a pharmaceutical (drug), medical device, or even a diagnostic test in some cases. Are you a great presenter?

Pharmaceutical Sales 52

Pharmaceutical Sales Pharma sales reps Pharma sales representatives Pharma sales representative 52